1. Home
  2. ACXP vs TRNR Comparison

ACXP vs TRNR Comparison

Compare ACXP & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • TRNR
  • Stock Information
  • Founded
  • ACXP 2017
  • TRNR 2017
  • Country
  • ACXP United States
  • TRNR United States
  • Employees
  • ACXP N/A
  • TRNR N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • TRNR Consumer Electronics/Appliances
  • Sector
  • ACXP Health Care
  • TRNR Technology
  • Exchange
  • ACXP Nasdaq
  • TRNR Nasdaq
  • Market Cap
  • ACXP 8.4M
  • TRNR 6.8M
  • IPO Year
  • ACXP 2021
  • TRNR 2023
  • Fundamental
  • Price
  • ACXP $0.47
  • TRNR $7.78
  • Analyst Decision
  • ACXP Strong Buy
  • TRNR
  • Analyst Count
  • ACXP 2
  • TRNR 0
  • Target Price
  • ACXP $10.00
  • TRNR N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • TRNR 855.5K
  • Earning Date
  • ACXP 08-08-2025
  • TRNR 08-13-2025
  • Dividend Yield
  • ACXP N/A
  • TRNR N/A
  • EPS Growth
  • ACXP N/A
  • TRNR N/A
  • EPS
  • ACXP N/A
  • TRNR N/A
  • Revenue
  • ACXP N/A
  • TRNR $6,373,000.00
  • Revenue This Year
  • ACXP N/A
  • TRNR $355.02
  • Revenue Next Year
  • ACXP N/A
  • TRNR N/A
  • P/E Ratio
  • ACXP N/A
  • TRNR N/A
  • Revenue Growth
  • ACXP N/A
  • TRNR 445.63
  • 52 Week Low
  • ACXP $0.30
  • TRNR $3.74
  • 52 Week High
  • ACXP $3.33
  • TRNR $1,040.00
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • TRNR 56.19
  • Support Level
  • ACXP $0.45
  • TRNR $3.74
  • Resistance Level
  • ACXP $0.59
  • TRNR $7.08
  • Average True Range (ATR)
  • ACXP 0.08
  • TRNR 0.99
  • MACD
  • ACXP -0.01
  • TRNR 0.31
  • Stochastic Oscillator
  • ACXP 27.06
  • TRNR 90.58

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: